Literature DB >> 10903368

Are RNA viruses adapting or merely changing?

M Sala1, S Wain-Hobson.   

Abstract

RNA viruses and retroviruses fix substitutions approximately 1 million-fold faster than their hosts. This diversification could represent an inevitable drift under purifying selection, the majority of substitutions being phenotypically neutral. The alternative is to suppose that most fixed mutations are beneficial to the virus, allowing it to keep ahead of the host and/or host population. Here, relative sequence diversification of different proteins encoded by viral genomes is found to be linear. The examples encompass a wide variety of retroviruses and RNA viruses. The smoothness of relative divergence spans quasispeciation following clonal infection, to variation among different isolates of the same virus, to viruses from different species or those associated with different diseases, indicating that the majority of fixed mutations likely reflects drift. This held for both mammalian and plant viruses, indicating that adaptive immunity doesn't necessarily shape the relative accumulation of amino acid substitutions. When compared to their hosts RNA viruses evolution appears conservative.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903368      PMCID: PMC7081970          DOI: 10.1007/s002390010062

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  12 in total

1.  Structure and temporal dynamics of populations within wheat streak mosaic virus isolates.

Authors:  J S Hall; R French; T J Morris; D C Stenger
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 2.  Molecular clocks and the puzzle of RNA virus origins.

Authors:  Edward C Holmes
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 3.  The evolution, distribution and diversity of endogenous retroviruses.

Authors:  Robert Gifford; Michael Tristem
Journal:  Virus Genes       Date:  2003-05       Impact factor: 2.332

4.  Epidemiology, genetic diversity, and evolution of endemic feline immunodeficiency virus in a population of wild cougars.

Authors:  Roman Biek; Allen G Rodrigo; David Holley; Alexei Drummond; Charles R Anderson; Howard A Ross; Mary Poss
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  Pleiotropic costs of niche expansion in the RNA bacteriophage phi 6.

Authors:  Siobain Duffy; Paul E Turner; Christina L Burch
Journal:  Genetics       Date:  2005-11-19       Impact factor: 4.562

6.  High variability and rapid evolution of a nanovirus.

Authors:  Ioana Grigoras; Tatiana Timchenko; Ana Grande-Pérez; Lina Katul; Heinrich-Josef Vetten; Bruno Gronenborn
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

7.  Analysis of the serotype and genotype correlation of VP1 and the 5' noncoding region in an epidemiological survey of the human enterovirus B species.

Authors:  Inge Thoelen; Elien Moës; Philippe Lemey; Sara Mostmans; Elke Wollants; A Michael Lindberg; Anne-Mieke Vandamme; Marc Van Ranst
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

8.  Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses.

Authors:  Elena Cherkasova; Majid Laassri; Vladimir Chizhikov; Ekaterina Korotkova; Eugenia Dragunsky; Vadim I Agol; Konstantin Chumakov
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-23       Impact factor: 11.205

9.  Estimation of the effective number of founders that initiate an infection after aphid transmission of a multipartite plant virus.

Authors:  Mónica Betancourt; Alberto Fereres; Aurora Fraile; Fernando García-Arenal
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

10.  Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner.

Authors:  Tim van Opijnen; Rienk E Jeeninga; Maarten C Boerlijst; Georgios P Pollakis; Veera Zetterberg; Mika Salminen; Ben Berkhout
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.